The Yale Center for the Science of Cannabis and Cannabinoids will foster studies into the acute and chronic effects of cannabinoids on neuronal and mental health.
Legalizing cannabis does not affect psychosis diagnoses or the prescription of antipsychotic medicines, a new study published in JAMA Network Open has found.
State regulators in Colorado have issued another health and safety notice after “potentially unsafe levels” of total yeast and mold and Aspergillus were found in a batch of cannabis flower.
The federal agency made its decision following a “careful review” of the potential regulatory pathways of CBD products in the US.
States that legalize recreational cannabis use also see a reduction in demand for prescription codeine, according to a new study.
Kaycha Labs is the first of seven state-certified labs to be cleared by the NY regulator to carry out all nine types of test.